Smoke-Free Homes Intervention for the Prevention of Smoking

Active:	Yes
Cancer Type:	Unknown Primary	NCT ID:	NCT04547686
Trial Phases:		Protocol IDs:	SFH-5A-RCT (primary) NCI-2021-01784 STUDY00001085
Eligibility:	18 Years and older, Male and Female	Study Type:	Prevention
Study Sponsor:	Emory University Hospital/Winship Cancer Institute
NCI Full Details:	http://clinicaltrials.gov/show/NCT04547686

Summary

This clinical trial studies the effect of a smoke-free homes intervention in preventing smoking. This study aims to see whether smoke-free home rules support smokers in changing their smoking behaviors.

Objectives

PRIMARY OBJECTIVES:
I. Partner with seven large Federally Qualified Health Center (FQHC)s in Georgia to conduct a randomized controlled trial to test the efficacy of integrating a robust smoke free home (SFH)s intervention into the 5A approach for tobacco cessation among FQHC patients.
II. Conduct a process evaluation of the expanded intervention to assess implementation outcomes, cost, and scalability potential.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive adapted smoke-free homes intervention including three interactive mailings at baseline, 4, and 6 weeks, and two coaching calls over 20-30 minutes each at 2 and 10 weeks. Participants are guided through 3 modules to make each space smoke-free. Participants who report quitting at the 6- and 12-month follow-up undergo collection of saliva and urine samples. Participants also receive mailed information on the quitline.

ARM II: Participants receive mailed information on the quitline. Participants who report quitting at the 6- and 12-month follow-up undergo collection of saliva and urine samples.

After completion of study, participants are followed up at 6 and 12 months.

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.